[1]涂彧.成人脑显像时组织吸收剂量及对患者的防护措施[J].国际放射医学核医学杂志,2001,25(3):115-120.
 TU Yu.The absorb doses and the safeguard for grown-up brain imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(3):115-120.
点击复制

成人脑显像时组织吸收剂量及对患者的防护措施(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
25
期数:
2001年第3期
页码:
115-120
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
The absorb doses and the safeguard for grown-up brain imaging
作者:
涂彧
215007 江苏苏州, 苏州大学放射医学系
Author(s):
TU Yu
Department of Radiomedicine, Suzhou university, Jiangsu Suzhou 215007, China
关键词:
成人脑显像吸收剂量
Keywords:
grown-upbrain imagingabsorb dose
分类号:
R817.4;X591
摘要:
脑显像是核医学诊断中的重要组成部分,临床诊断上应用很广,在诊断过程中,不同的疾病、不同的诊断方法、不同的试剂对患者可能产生不同的吸收剂量。为了不使患者接受不必要的辐射剂量,降低放射性核素诊断的风险,有必要采取包括阻吸收、促排、替代以及建立、健全诊断过程前中后的质量保证体系等措施来保护患者。
Abstract:
Grown-up brain imaging is one of the very important measures for diagnosing in clinic nuclear medicine.The patients will receive different absorb doses when they have different illness or diagnosed by different measures and different reagents. Obstructing absorbability, promoting excretion, substitution and perfect quality assuring sys-tem are necessary measures to reduce patient’s absorb doses and risks caused by isotopes diagnoses.

参考文献/References:

[1] UNSCEAR.电离辐射源与效应——联合国原子辐射效应科学委员会 1993年向联合国大会提交的报告和科学附件[M].北京:原子能出版社,1995.249-258.
[2] ICRP.国际放射防护委员会53号出版物 放射性药物对患者产生的辐射剂量[M].北京:原子能出版社,1991.55-58.
[3] Isobe Y,Yamamoto Y,Nishiyama Y,et al.Markedly increased accumulation of Tc-99m DT PA in a patient with neurofibromatosis[J].Clin Nucl Med,1998,23(8):557-559.
[4] Suga K,Hirabayshi A,Kishimoto K,et al.Tc-99m DTPA used as reference imaging to evaluate the distri-bution of other tumor-seeking tracers in tumors associ-ated with neurofibromatosis[J].Clin Nucl Med,1999,24(6):435-439.
[5] Miyazawa N,Koizumi K,Mitsuka S,et al.Discrepan-cies in brain perfusion SPECT findings between Tc-99m HM PAO and Tc-99m ECD:evaluation using dy-namic SPECT in patients with hyperemia[J].Clin Nucl Med,1998,23(10):686-690.
[6] Hashimoto J,Sasaki T,Itoh Y,et al.Brain SPECT imaging using three different tracers in subacute cere-bral infarction[J].Clin Nucl Med,1998,23(5):275-277.
[7] Lauriero F,Rubini G,Addabbo F,et al.I-131 MIBG scintigraphy of neuroectodermal tumors.Comparison between I-131 MIBG and In-111 DTPA-octreotide[J].Clin Nucl Med,1995,20(3):243-249.
[8] Flores LG,Jinnouchi S,Nagamachi S,et al.rCBF in neurodegenerative diseases as estimated by the autora-diographic (ARG) method and delayed I-123-IMP studies[J].Ann Nucl Med,1999,13(5):281-285.
[9] Hayashida K,Fukuchi K,Hasegawa Y,et al.Viable tis-sue in an area of severely reduced perfusion demon-strated with I-123 iomazenil brain SPECT imaging of benzodiazepine receptors[J].Clin Nucl Med,1999,24(8):576-578.
[10] Dresel S,Tatsch K,Dahne I.Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients[J].J Nucl Med,1998,39(7):1138-1142.
[11] Dresel S,Mager T,Rossmuller B,et al.In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients:an iodine-123 iodobenzamide single-photon emission tomography study[J].Eur J Nucl Med,1999,26(8):862-868.
[12] Facco E,Munari M,Behr AU,et al.Assessment of brain perfusion in coma and comparison between SPECT and CT scan data:preliminary report[J].Neu-rol Res,1998,20(Suppl 1):S40-S43.
[13] Iranzo A,Marti FJ,Domingo P,et al.Absence of Thal-lium-201 brain uptake in progressive multifocalleukoencephalopathy in AIDS patients[J].Acta Neurol Scand,1999,100(2):102-105.
[14] Ronin B,Marsden PK,O’Doherty M J.Are restrictions to behaviour of patients required following fluorine-18 fluorodexyglucose positron emission tomographic stud-ies?[J].Eur J Nucl Med,1999,26(2):121-128.
[15] Seabold JE,Simonson TM,Weber PC,et al.Cranial os-teomyelitis:diagnosis and follow-up with In-111 white blood cell and Tc-99m methylene diphosphonate bone SPECT,CT,and MR imaging[J].Radiology,1995,196(3):779-788.
[16] Stokking R,Zuiderveld KJ,Hulshoff PHE,et al.Nor-mal fusion for three-dimensional integrated visualiza-tion of SPECT and magnetic resonance brain images[J].J Nucl Med,1997,38(4):624-629.
[17] Graham LS.Quality control for SPECT systems[J].Radiographics,1995,15(6):1471-1481.
[18] Williams BS,Hinkle GH,Lamatrice RA,et al.Techni-cal considerations for acquiring and processing Indium-111 capromab pendetide images[J].JNucl Med Tech-nol,1997,25(3):205-216.
[19] Barnes A,Dai D,Montaldi D,et al.Image quality ver-sus statistical power[J].Nucl Med Commun,1997,18(12):1155-1160.

相似文献/References:

[1]何再防,李红兵,程寿林,等.百草枯中毒肺损伤的CT表现与临床意义[J].国际放射医学核医学杂志,2012,36(1):56.[doi:10.3760/cma.j.issn.1673-4114.2012.01.014]
 HE Zai-fang,LI Hong-bing,CHENG Shou-lin,et al.Finding of CT and clinical in paraquat poisoning pulmonary injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):56.[doi:10.3760/cma.j.issn.1673-4114.2012.01.014]
[2]郭万华.统计参数图在PET和SPECT脑功能显像中的应用[J].国际放射医学核医学杂志,2002,26(1):7.
 GUO Wan-hua.Application of statistical parametric mapping in PET and SPECT brain functional imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(3):7.

备注/Memo

备注/Memo:
收稿日期:2000/9/25。
作者简介:涂彧(1965-),男,江西进贤人,苏州大学放射医学系放射卫生教研室副教授,硕士导师,博士研究生,主要从事医疗照射的防护研究。
更新日期/Last Update: 1900-01-01